You Know You’re Safe. Your Body Disagrees.
The spider is behind glass. You’ve checked. It cannot get out, and you have absolutely no intention of getting in. Still, your heart is racing, your palms are sweating, and you’re already calculating the quickest way to the door.
You could explain every reason you’re safe and still find yourself backing away. Fear can be remarkably unimpressed by a good argument.
But what if that reaction could change much faster than you ever thought possible?
Researchers studying a process called memory reconsolidation are investigating whether briefly reactivating a fear memory can create an opportunity to change the emotional response associated with it. The memory itself would remain, but the fear it triggers might become considerably less powerful.
Some experiments involving specific fears have produced striking results after a single intervention. That doesn’t mean PTSD can be cured overnight, or that a frightening memory can simply be erased. The science is more complicated than that.
Still, consider what it would mean to look at that same spider, remember exactly why it used to terrify you, and realize you no longer feel the need to run.
Your Brain’s Memories May Be More Editable Than You Think
Getting rid of the fear may not require getting rid of the memory.
We tend to think of memories as recordings stored somewhere in the brain, waiting to be played back whenever we need them. But remembering isn’t always a passive process. Under certain conditions, recalling something can briefly make aspects of that memory susceptible to change before they become stable again. Researchers call this memory reconsolidation.
Think of opening a saved document. Most of the time, you read what’s there and close it without changing anything. Occasionally, though, you have the opportunity to make a revision before saving it again. Memory is considerably more complicated, but the comparison helps explain what researchers are trying to understand.
One important piece of the puzzle is something called prediction error. This occurs when what you expect to happen doesn’t match what actually happens. You see a spider, anticipate danger, and encounter something different from what your fear has taught you to expect. Under the right conditions, that mismatch may help make the learned fear response more susceptible to change.
The difficulty is figuring out what those conditions are. Simply remembering something frightening doesn’t reliably open a window for reconsolidation. Even an unexpected experience may not be enough. The timing, the nature of the memory, and what happens during its reactivation all appear to matter.
And that distinction is important. Researchers aren’t necessarily trying to remove someone’s knowledge of a frightening event. They’re investigating whether the brain can retain that knowledge without continuing to produce the same intensity of fear.
You might still remember how terrified you once were of spiders. You might even remember the exact moment that fear began. But perhaps the next time you encounter one, you notice something has changed.
Your heart isn’t pounding. You’re not searching for the nearest exit. For once, you’re simply looking at a spider.
A Spider, a Beta-Blocker, and a Surprising Result
In 2015, researchers recruited 45 people with a significant fear of spiders and divided them into three groups. Participants in two of those groups were instructed to approach a live tarantula in an open enclosure, stopping approximately two feet away. They believed they would eventually have to touch it.
After two minutes, the encounter ended. Nobody had to touch the spider.
One group then received propranolol, a beta-blocker commonly prescribed for certain cardiovascular conditions. Another received a placebo. A third group received propranolol without first encountering the tarantula.
The researchers wanted to know whether giving propranolol shortly after reactivating a fear memory could interfere with the process that ordinarily allows the memory to become stable again.
Four days later, the participants returned for testing.
All 15 people who had encountered the tarantula and received propranolol were willing to touch it. Participants in the other two groups remained substantially more hesitant, with many barely approaching or touching its container.
The researchers continued following participants, and the behavioral improvements in the combined spider-exposure and propranolol group remained evident a year later. Interestingly, the change in how participants approached spiders appeared before their own reports of fear fully caught up.
For people who had previously struggled to stand near a spider, being able to reach out and touch one represented an extraordinary change.
But there are important qualifications. The study was small, involved people with significant spider fears rather than diagnosed PTSD, and first assessed the dramatic behavioral change four days after the intervention. It did not establish that fear could reliably disappear within 24 hours.
Subsequent research also raised questions about how the treatment works and what makes its effects last. In a later study, participants receiving a placebo showed early improvements, too. Over the longer term, the propranolol intervention produced better results when participants encountered spiders again within days of treatment. Without that early encounter, the lasting advantage was not apparent.
That finding suggests the medication alone may not be the whole story. What happens after treatment could be just as important in determining whether the improvement lasts.
Researchers still have work to do before they can explain precisely why some people experience such dramatic changes while others do not.
Even with those uncertainties, the original finding is difficult to dismiss as uninteresting. People who had spent years avoiding spiders were suddenly able to approach and touch one.
What remains unclear is how reliably that change can be reproduced, and whether the same principles can help people struggling with more complicated forms of fear.
What Happens When Researchers Try This With PTSD?
A car backfires outside a grocery store. Most shoppers barely notice. But someone who survived a shooting might instinctively duck, gripping the handle of their cart while searching for the nearest exit. By the time they recognize the sound, their hands are already trembling.
They know they’re standing in a grocery store. They know the shooting happened years ago. Neither fact necessarily stops their body from responding as though the danger has returned.
That is part of what makes post-traumatic stress disorder so difficult. Trauma can affect far more than someone’s reaction to a particular reminder. It can disrupt sleep, strain relationships, interfere with concentration, and make otherwise ordinary experiences feel threatening.
Researchers have been investigating whether memory reconsolidation could help reduce some of those responses.
In 2018, a randomized clinical trial involving 60 adults with PTSD produced encouraging findings. Participants received either propranolol or a placebo before briefly revisiting traumatic memories during six weekly treatment sessions. Those given propranolol experienced greater reductions in PTSD symptoms.
The results suggested that combining medication with carefully timed memory reactivation might offer benefits beyond the memory reactivation procedure itself.
But in 2021, another randomized trial involving 66 adults found something different.
Both groups experienced substantial symptom improvement over six weekly sessions, regardless of whether they received propranolol or a placebo. Immediately after treatment, propranolol offered no clear overall advantage. Although researchers observed a possible later benefit among participants with more severe initial symptoms, the broader findings were less convincing than those of the earlier trial.
This leaves researchers with an important question: what was actually helping?
Revisiting traumatic memories in a structured therapeutic setting may itself contribute to symptom improvement. Expectations about treatment can also influence outcomes. And even when symptoms improve considerably, that doesn’t necessarily establish that the underlying memory reconsolidation process was disrupted.
There’s another complication. PTSD involves more than a single learned fear response. The effects of trauma can become intertwined with someone’s sense of safety, relationships, beliefs about themselves, and expectations of the world. A procedure that changes how someone responds to a spider cannot automatically be expected to address all of those difficulties.
None of this makes the research unimportant. It means the findings need to be understood in context, without turning early scientific possibilities into promises of treatment outcomes.
For someone standing frozen in that grocery aisle, the distinction between different memory processes may not matter much in the moment.
What matters is whether, someday, they can hear that sudden noise, recognize what happened, and continue pushing their cart.
Could Brain Stimulation Help Change the Response?
Medication isn’t the only approach researchers have explored. Scientists are also studying whether targeted magnetic stimulation can influence fear memories after they’ve been reactivated.
In a 2025 study, 34 people with a fear of spiders spent three minutes near a live tarantula. Ten minutes later, some participants received a form of transcranial magnetic stimulation, a noninvasive procedure that uses magnetic pulses to influence activity in targeted brain regions. Others received a sham procedure designed to resemble the treatment without delivering the same stimulation.
The researchers wanted to know whether stimulating the brain shortly after a fear memory had been activated could influence how participants responded to spiders later.
Both groups became less fearful, but magnetic stimulation showed no clear overall advantage over the sham procedure.
There was, however, an interesting finding in the additional analyses. Participants who received stronger stimulation tended to show greater reductions in spider fear. That relationship was exploratory, meaning it raises a possibility worth investigating rather than demonstrating that the treatment works.
The results also leave open whether the improvement came from the memory reactivation experience, the stimulation, or other factors involved in participating in the study.
For now, magnetic stimulation remains an experimental approach in this area. Whether researchers can use it to produce reliable, lasting changes in fear responses, much less meaningful improvements in PTSD, remains uncertain.
Still, the investigation reflects how much our understanding of memory has changed. Researchers are no longer asking only how frightening memories are formed and stored. They’re also trying to understand what happens when those memories become active again, and whether that moment creates an opportunity for something different to happen.
Why “Erasing Trauma” Is the Wrong Promise
A familiar song comes on while someone is driving home. For years, those first few notes have sent their hand straight to the radio. The music brings back something they would rather not revisit, and turning it off has become almost automatic.
Now imagine hearing that scientists might be able to erase that painful memory in 24 hours.
For someone who has spent years struggling with trauma, the appeal is understandable. When a memory continues to affect your life long after the event itself has ended, forgetting can sound like the simplest form of relief.
But recovery doesn’t have to mean forgetting.
A person might still remember what happened without experiencing the same overwhelming response whenever something brings it to mind. They might begin sleeping through the night, feel comfortable attending family gatherings again, or find that places they once avoided no longer seem quite so threatening.
Those changes can be deeply meaningful, even when they happen gradually.
And that’s part of the problem with headlines promising an overnight cure. They create expectations that the research cannot yet support. Someone who has spent months working through trauma may read about a dramatic laboratory result and wonder why their own progress has been so much slower.
The comparison is unfair, particularly when the studies involve different conditions, carefully controlled procedures, and small groups of participants.
Recovery rarely follows a schedule. Some symptoms improve before others. Progress can be interrupted by setbacks, and the changes that matter most to someone may not be the ones that make for an exciting research headline.
None of that diminishes the importance of finding treatments that work more quickly. It simply means that speed shouldn’t become the measure of whether someone’s recovery is worthwhile.
The memory may never disappear. The person driving home may always recognize that familiar song and remember why it once hurt to hear it.
But one afternoon, the song might come on, and their hand stays on the steering wheel.
What You Can Do With This Information Today
Reading about a promising scientific discovery is one thing. Deciding whether it has any practical relevance to your own treatment is another.
If trauma or anxiety is interfering with your life, begin by asking a qualified mental health professional which treatment have the strongest evidence for your particular symptoms. Find out what those treatments involve, what you can reasonably expect, and how you’ll know whether you’re making progress.
If someone offers a treatment based on memory reconsolidation, ask which procedure they use, what research supports it, and how they evaluate the results. Those are reasonable questions to ask about any treatment, especially one involving an emerging area of research.
And if propranolol is part of the discussion, speak with a qualified prescriber about whether it’s medically appropriate for you. Taking a beta- blocker and deliberately revisiting painful memories on your own is neither an established treatment nor a safe shortcut.
It also helps to think about what improvement would look like in your everyday life. Maybe you’ve stopped visiting someone you care about, attending family celebrations, or going somewhere you once enjoyed. Choosing one specific activity you’d like to return to can give you and your clinician something meaningful to work toward.
Because ultimately, the goal isn’t to produce an impressive change on a research questionnaire. It’s to make a difference in the life you’re actually living.
So here’s something worth considering: If fear had less influence over your decisions, what would you want to do differently?
If this research raises questions for you, feel free to share them in the comments. You don’t need to disclose anything personal to be part of the conversation.
Perhaps there’s an invitation sitting on your refrigerator right now. You’ve thought about throwing it away because you’ve already decided you won’t go. Not because you don’t want to be there, but because you know how difficult getting there might feel.
Maybe one day you look at that invitation, reach for your phone, and ask what time you should arrive.
Sources
Brunet, Alain, Daniel Saumier, Aihua Liu, David L. Streiner, Jacques Tremblay, and Roger K. Pitman. “Reduction of PTSD Symptoms with Pre- Reactivation Propranolol Therapy: A Randomized Controlled Trial.” American Journal of Psychiatry 175, no. 5 (2018): 427 — 33.
Herrmann, Martin J., Daniela Schaub, Georg C. Ziegler, Andreas Mühlberger, and Lisa M. Cybinski. “Disrupting Fear Memory Reconsolidation in Individuals with Fear of Spiders with cTBS: A Proof-of-Concept Study.” Behavioural Brain Research 491 (2025): 115644.
Peters, Jacqueline, Anna I. Filmer, Johnny B. van Doorn, Vivian N. Metselaar, Renée M. Visser, and Merel Kindt. “Re-Encountering the Phobic Cue within Days after a Reconsolidation Intervention Is Crucial to Observe a Lasting Fear Reduction in Spider Phobia.” Molecular Psychiatry 30, no. 6 (2025): 2729 — 38..
Roullet, Pascal, Guillaume Vaiva, Etienne Véry, Axel Bourcier, Antoine Yrondi, Laetitia Dupuch, Pierre Lamy, et al. “Traumatic Memory Reactivation with or without Propranolol for PTSD and Comorbid MD Symptoms: A Randomised Clinical Trial.” Neuropsychopharmacology 46, no. 9 (2021): 1643 — 49.
Sevenster, Dieuwke, Tom Beckers, and Merel Kindt. “Prediction Error Governs Pharmacologically Induced Amnesia for Learned Fear.” Science 339, no. 6121 (2013): 830 — 33.
Soeter, Marieke, and Merel Kindt. “An Abrupt Transformation of Phobic Behavior after a Post-Retrieval Amnesic Agent.” Biological Psychiatry 78, no. 12 (2015): 880 — 86.